House FDA reform bill contains Delaney revisions, national uniformity provisions.
This article was originally published in The Rose Sheet
Executive Summary
DELANEY CLAUSE REVISIONS ADDRESSED IN HOUSE FDA REFORM MEASURE released by the House Commerce Committee March 29. Sponsored by Rep. Scott Klug (R-Wis.), the FDA reform bill addressing foods will replace the Delaney Clause's "zero cancer risk" standard for food and color additives and animal drugs with a negligible or de minimus risk standard.